Company Filing History:
Years Active: 1995-2006
Title: David G Osterman: Innovator in Enzyme Activity and Immunosuppressants
Introduction
David G Osterman is a notable inventor based in Glastonbury, Connecticut. He holds a total of 5 patents that contribute significantly to the fields of enzyme activity assessment and immunosuppressant compounds. His work has implications for various medical conditions, including diabetes and cancer.
Latest Patents
One of Osterman's latest patents is a method for assaying enzyme activity. This invention relates to methods for assessing enzyme activity utilizing a phase partition system. It also includes methods for screening and identifying compounds that may be used for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders. Another significant patent involves 2-oxoethyl derivatives as immunosuppressants. This patent discloses a class of compounds that suppress human T-lymphocyte proliferation, with active compounds containing specific structural features.
Career Highlights
Throughout his career, Osterman has worked with prominent companies such as Miles Inc. and Bayer Pharmaceuticals Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical and biotechnology sectors.
Collaborations
Osterman has collaborated with notable professionals in his field, including Richard D Connell and Michael E Katz. These collaborations have likely contributed to the advancement of his research and patent developments.
Conclusion
David G Osterman is a distinguished inventor whose work in enzyme activity and immunosuppressants has made a significant impact in the medical field. His contributions continue to influence research and development in addressing critical health issues.